Hjem › Spinal muskelatrofi › Illinois
Spinal muskelatrofi kliniske forsøg i Illinois
6 studier for Spinal muskelatrofi søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- Ann and Robert H. Lurie Children Hospital of Chicago, Chicago
RekruttererFase 4
3 Months – 24 Months · Alle køn · Opdateret 2. okt. 2026 · NCT05861986A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 2
Alder 5 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT07287982A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 1
Alder 3 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Lurie Childrens Hospital, Chicago
Rekrutterer
Alder 3 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
RekruttererFase 3
0 Days – 42 Days · Alle køn · Opdateret 18. aug. 2026 · NCT07221669ALS/MND Natural History Study Data Repository
- Northwestern University, Chicago
RekruttererObservationsstudie
Alder 18 til 90 · Alle køn · Opdateret 20. maj 2026 · NCT05966038Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.